hydralazine has been researched along with Histiocytoma, Benign Fibrous in 1 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Histiocytoma, Benign Fibrous: A benign tumor composed, wholly or in part, of cells with the morphologic characteristics of HISTIOCYTES and with various fibroblastic components. Fibrous histiocytomas can occur anywhere in the body. When they occur in the skin, they are called dermatofibromas or sclerosing hemangiomas. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 5th ed, p1747)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Field, SB | 1 |
| Needham, S | 1 |
| Burney, IA | 1 |
| Maxwell, RJ | 1 |
| Coggle, JE | 1 |
| Griffiths, JR | 1 |
1 other study available for hydralazine and Histiocytoma, Benign Fibrous
| Article | Year |
|---|---|
Differences in vascular response between primary and transplanted tumours.
Topics: Animals; Fibroma; Fibrosarcoma; Histiocytoma, Benign Fibrous; Hydralazine; Magnetic Resonance Spectr | 1991 |